Systematic Review on the Efficacy of Multimodal Treatment of Sarcomatosis with Cytoreduction and Intraperitoneal Chemotherapy

@article{Munene2010SystematicRO,
  title={Systematic Review on the Efficacy of Multimodal Treatment of Sarcomatosis with Cytoreduction and Intraperitoneal Chemotherapy},
  author={Gitonga Munene and FRCSC Lloyd A. Mack and FRCSC FACS Walley J. Temple},
  journal={Annals of Surgical Oncology},
  year={2010},
  volume={18},
  pages={207-213}
}
Peritoneal sarcomatosis carries a dismal prognosis with median survival of 12 months and no 5-year survivors. The treatment for sarcomatosis has mostly been chemotherapy and surgery for palliation. Recently, cytoreduction (CRS) and intraperitoneal chemotherapy (IPC) has been tried as an alternative for improving regional control and survival, but the efficacy of this combined treatment is difficult to determine. The objective of this review is to evaluate all available evidence to determine the… CONTINUE READING